Cargando…

Cervical Cancer and Fertility-Sparing Treatment

Radical hysterectomy with pelvic node dissection is the standard treatment for early-stage cervical cancer. However, the latter can be diagnosed at a young age when patients have not yet achieved their pregnancy plans. Dargent first described the vaginal radical trachelectomy for patients with tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaccarini, François, Sanson, Claire, Maulard, Amandine, Schérier, Stéphanie, Leary, Alexandra, Pautier, Patricia, Chargari, Cyrus, Genestie, Catherine, Gouy, Sébastien, Morice, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585101/
https://www.ncbi.nlm.nih.gov/pubmed/34768345
http://dx.doi.org/10.3390/jcm10214825
_version_ 1784597610205544448
author Zaccarini, François
Sanson, Claire
Maulard, Amandine
Schérier, Stéphanie
Leary, Alexandra
Pautier, Patricia
Chargari, Cyrus
Genestie, Catherine
Gouy, Sébastien
Morice, Philippe
author_facet Zaccarini, François
Sanson, Claire
Maulard, Amandine
Schérier, Stéphanie
Leary, Alexandra
Pautier, Patricia
Chargari, Cyrus
Genestie, Catherine
Gouy, Sébastien
Morice, Philippe
author_sort Zaccarini, François
collection PubMed
description Radical hysterectomy with pelvic node dissection is the standard treatment for early-stage cervical cancer. However, the latter can be diagnosed at a young age when patients have not yet achieved their pregnancy plans. Dargent first described the vaginal radical trachelectomy for patients with tumors <2 cm. It has since been described a population of low risk of recurrence: patients with tumors <2 cm, without deep stromal infiltration, without lymphovascular invasion (LVSI), and with negative lymph nodes. These patients can benefit from a less radical surgery such as conization or simple trachelectomy with the evaluation of the pelvic node status. Tumors larger than 2 cm have a higher risk of recurrence and their treatment is a challenge. There are currently two options for these patients: abdominal radical trachelectomy or neoadjuvant chemotherapy (NACT), followed by fertility-sparing surgery. All patients who wish to preserve their fertility must be referred to expert centers.
format Online
Article
Text
id pubmed-8585101
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85851012021-11-12 Cervical Cancer and Fertility-Sparing Treatment Zaccarini, François Sanson, Claire Maulard, Amandine Schérier, Stéphanie Leary, Alexandra Pautier, Patricia Chargari, Cyrus Genestie, Catherine Gouy, Sébastien Morice, Philippe J Clin Med Review Radical hysterectomy with pelvic node dissection is the standard treatment for early-stage cervical cancer. However, the latter can be diagnosed at a young age when patients have not yet achieved their pregnancy plans. Dargent first described the vaginal radical trachelectomy for patients with tumors <2 cm. It has since been described a population of low risk of recurrence: patients with tumors <2 cm, without deep stromal infiltration, without lymphovascular invasion (LVSI), and with negative lymph nodes. These patients can benefit from a less radical surgery such as conization or simple trachelectomy with the evaluation of the pelvic node status. Tumors larger than 2 cm have a higher risk of recurrence and their treatment is a challenge. There are currently two options for these patients: abdominal radical trachelectomy or neoadjuvant chemotherapy (NACT), followed by fertility-sparing surgery. All patients who wish to preserve their fertility must be referred to expert centers. MDPI 2021-10-21 /pmc/articles/PMC8585101/ /pubmed/34768345 http://dx.doi.org/10.3390/jcm10214825 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Zaccarini, François
Sanson, Claire
Maulard, Amandine
Schérier, Stéphanie
Leary, Alexandra
Pautier, Patricia
Chargari, Cyrus
Genestie, Catherine
Gouy, Sébastien
Morice, Philippe
Cervical Cancer and Fertility-Sparing Treatment
title Cervical Cancer and Fertility-Sparing Treatment
title_full Cervical Cancer and Fertility-Sparing Treatment
title_fullStr Cervical Cancer and Fertility-Sparing Treatment
title_full_unstemmed Cervical Cancer and Fertility-Sparing Treatment
title_short Cervical Cancer and Fertility-Sparing Treatment
title_sort cervical cancer and fertility-sparing treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585101/
https://www.ncbi.nlm.nih.gov/pubmed/34768345
http://dx.doi.org/10.3390/jcm10214825
work_keys_str_mv AT zaccarinifrancois cervicalcancerandfertilitysparingtreatment
AT sansonclaire cervicalcancerandfertilitysparingtreatment
AT maulardamandine cervicalcancerandfertilitysparingtreatment
AT scherierstephanie cervicalcancerandfertilitysparingtreatment
AT learyalexandra cervicalcancerandfertilitysparingtreatment
AT pautierpatricia cervicalcancerandfertilitysparingtreatment
AT chargaricyrus cervicalcancerandfertilitysparingtreatment
AT genestiecatherine cervicalcancerandfertilitysparingtreatment
AT gouysebastien cervicalcancerandfertilitysparingtreatment
AT moricephilippe cervicalcancerandfertilitysparingtreatment